Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Koó

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Orvosi Hetilap|January 28, 1990
[Gold salts in the treatment of psoriatic arthritis]E Koó, M Seszták
Zeitschrift Fur Rheumatologie|March 8, 2003
Measurement of disease activity in psoriatic arthritis. Extended reportI Ujfalussy, E Koó
The Journal of Rheumatology|April 12, 2001
Termination of disease modifying antirheumatic drugs in psoriatic arthritisI Ujfalussy, E Koó, M Seszták
Clinical Rheumatology|September 1, 1991
Juvenile psoriatic arthritisE Koó, Z Balogh, B Gömör
Acta Medica Hungarica|January 1, 1983
Adrenocortical function in bronchial asthmaK G Fehér, E Koó, T Fehér
Orvosi Hetilap|April 16, 1995
[Diagnosis and differential diagnosis of psoriatic arthritis on basis of follow up of 215 cases]M Seszták, E Koó, V Farkas, et al.
Clinical and Experimental Rheumatology|May 1, 2001
Systemic, secondary amyloidosis in a patient with psoriatic arthritisI Ujfalussy, M Bély, E Koó, et al.
Orvosi Hetilap|December 8, 1991
[How to choose a basic drug for psoriatic arthritis?]E Koó, M Seszták, F Gyulai, et al.
Orvosi Hetilap|October 8, 1972
[Hereditary angioneurotic edema, analysis of 3 cases]I Raffai, G Füst, E Koó, et al.
Orvosi Hetilap|August 5, 1973
[Hazards and complications of propanidid (epontol, sombrevin) anesthesia]K Szántó, E Koó, L Kónya, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Orvosi Hetilap|January 28, 1990
[Gold salts in the treatment of psoriatic arthritis]E Koó, M Seszták
Zeitschrift Fur Rheumatologie|March 8, 2003
Measurement of disease activity in psoriatic arthritis. Extended reportI Ujfalussy, E Koó
The Journal of Rheumatology|April 12, 2001
Termination of disease modifying antirheumatic drugs in psoriatic arthritisI Ujfalussy, E Koó, M Seszták
Clinical Rheumatology|September 1, 1991
Juvenile psoriatic arthritisE Koó, Z Balogh, B Gömör
Acta Medica Hungarica|January 1, 1983
Adrenocortical function in bronchial asthmaK G Fehér, E Koó, T Fehér
Orvosi Hetilap|April 16, 1995
[Diagnosis and differential diagnosis of psoriatic arthritis on basis of follow up of 215 cases]M Seszták, E Koó, V Farkas, et al.
Clinical and Experimental Rheumatology|May 1, 2001
Systemic, secondary amyloidosis in a patient with psoriatic arthritisI Ujfalussy, M Bély, E Koó, et al.
Orvosi Hetilap|December 8, 1991
[How to choose a basic drug for psoriatic arthritis?]E Koó, M Seszták, F Gyulai, et al.
Orvosi Hetilap|October 8, 1972
[Hereditary angioneurotic edema, analysis of 3 cases]I Raffai, G Füst, E Koó, et al.
Orvosi Hetilap|August 5, 1973
[Hazards and complications of propanidid (epontol, sombrevin) anesthesia]K Szántó, E Koó, L Kónya, et al.
Pageof 3